BBCNEWS BBC News June 4, 2024 16:41:00
Less of this amyloid inside it, and that's how these therapies are working. james, that's absolutely fascinating. and if it works, fantastic, but of course people have to have access to it. yeah, there are two massive problems here. so, the first one is going to be the cost. so we know how much this drug, the one from last year, it's about $25,000 per person per year. we don't know how much donanemab, the one that's been reported more recently, is going to cost, but these are going to be expensive drugs and that immediately rules it out for huge numbers of people all around the world. the seco...